glp-1 for bulimia Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review GLP-1 Medications, Messaging, and Eating

FIGURE 1 3.2 Study characteristics Supplementary Table S2 provides an overview of the key features of the included studies, including: (1) first author, (2) publication year, (3) animal species, sample size per group, weight, and sex

Animal studies have shown potential risks to fetal development, and there is insufficient data on their safety in human pregnancy

A literature review that appeared in Molecular Psychiatry in July was the latest and perhaps loudest death knell for the serotonin hypothesis, at least in its simplest form

Early dosing is not appropriate as a regular pattern or workaround for missed doses